Rockbridge Investment Management’s GSK GSK Stock Holding History

Rockbridge Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16	Closed	-$593	–	327
2023 Q4	$593	Buy	+16	New	+$574	﹤0.01%	609
2022 Q3	–	Sell	-636	Closed	-$34.6K	–	304
2022 Q2	$34.6K	Hold	636	–	–	0.01%	252
2022 Q1	$34.9K	Buy	636 +620	+3,875%	+$33.7K	0.01%	345
2021 Q4	$1K	Hold	16	–	–	﹤0.01%	757
2021 Q3	$1K	Hold	16	–	–	﹤0.01%	708
2021 Q2	$1K	Hold	16	–	–	﹤0.01%	701
2021 Q1	$1K	Sell	16 -784	-98%	-$35.6K	﹤0.01%	681
2020 Q4	$37K	Hold	800	–	–	0.01%	326
2020 Q3	$38K	Hold	800	–	–	0.01%	297
2020 Q2	$41K	Buy	+800	New	+$41K	0.01%	252

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockbridge Investment Management's GSK Position: Q1 2024 in Review

Rockbridge Investment Management sold out of GSK (GSK) in Q1 2024, closing a stake of 16 shares — an estimated $593 sold.

Rockbridge Investment Management first reported a position in GSK in Q2 2020 and held it in 10 quarters. The position peaked at $41K in Q2 2020. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

Rockbridge Investment Management reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 16 GSK shares in Q1 2024, an estimated $593.
Rockbridge Investment Management first reported a position in GSK in Q2 2020 and held it in 10 quarters.
Rockbridge Investment Management's GSK position peaked at $41K in Q2 2020.
910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.